Integrated Universal Experimentally-Validated Artificial Intelligence for Every Step of Pharmaceutical Research and Development
Our Mission is to accelerate drug discovery and drug development by continuously inventing and deploying new artificial intelligence technologies
We provide artificial intelligence solutions to the top industry players and use these solutions internally to develop a pipeline of therapeutic programs in cancer, fibrosis, antiinfectives, immunology, and senescence
We aspire to be a leader in the field of deep learning for drug discovery and development by relentlessly innovating, publishing proofs of concept in peer-reviewed academic journals, and delivering great AI software for the top industry experts
Introducing fully-integrated drug discovery software suite
PHARMA.AI OPERATING SYSTEM
Potential 2019-nCoV 3C-like protease inhibitors designed using generative chemistry approaches
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Our latest publication in Nature Biotechnology
AI Pharma Pipeline
We developed a comprehensive drug discovery engine, which utilizes millions of samples and multiple data types to discover signatures of disease and identify the most promising targets for billions of molecules that already exist or can be generated de novo with the desired set of parameters.
Over 150 Academic and Industry Collaborators Worldwide
We have a great pleasure to work with the leading companies and institutions to provide next-level solutions for drug discovery and biomarker development.